Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T MacLaughlin

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Experimental Neurology|January 4, 2011
Müllerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neuronsAndrew N Clarkson, Caroline L Talbot, Pei-Yu Wang, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 28, 2004
Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor geneMakiko Hoshiya, Benjamin P Christian, William J Cromie, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 3, 2011
Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosisMikko Anttonen, Anniina Färkkilä, Hanna Tauriala, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2005
Mullerian inhibiting substance acts as a motor neuron survival factor in vitroPei-Yu Wang, Kyoko Koishi, Andrew B McGeachie, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadismNelly Pitteloud, Frances J Hayes, Paul A Boepple, et al.
Biology of Reproduction|October 31, 2003
Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablationAntonio Salva, Matthew P Hardy, Xiu-feng Wu, et al.
Cancer Research|March 17, 2007
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanismVandana Gupta, Giminna Yeo, Hirofumi Kawakubo, et al.
Development (Cambridge, England)|May 12, 2006
Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regressionYong Zhan, Akihiro Fujino, David T MacLaughlin, et al.
International Journal of Oncology|February 16, 2017
Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathwaySang Ho Park, Youn Jee Chung, Jae Yen Song, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2012
Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosisJeong Namkung, Jae Yen Song, Hyun Hee Jo, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Experimental Neurology|January 4, 2011
Müllerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neuronsAndrew N Clarkson, Caroline L Talbot, Pei-Yu Wang, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 28, 2004
Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor geneMakiko Hoshiya, Benjamin P Christian, William J Cromie, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 3, 2011
Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosisMikko Anttonen, Anniina Färkkilä, Hanna Tauriala, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2005
Mullerian inhibiting substance acts as a motor neuron survival factor in vitroPei-Yu Wang, Kyoko Koishi, Andrew B McGeachie, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadismNelly Pitteloud, Frances J Hayes, Paul A Boepple, et al.
Biology of Reproduction|October 31, 2003
Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablationAntonio Salva, Matthew P Hardy, Xiu-feng Wu, et al.
Cancer Research|March 17, 2007
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanismVandana Gupta, Giminna Yeo, Hirofumi Kawakubo, et al.
Development (Cambridge, England)|May 12, 2006
Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regressionYong Zhan, Akihiro Fujino, David T MacLaughlin, et al.
International Journal of Oncology|February 16, 2017
Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathwaySang Ho Park, Youn Jee Chung, Jae Yen Song, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2012
Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosisJeong Namkung, Jae Yen Song, Hyun Hee Jo, et al.
Pageof 5